COMMUNIQUÉS West-GlobeNewswire

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting
25/06/2024
ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of functional improvements with [...]
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
25/06/2024
KANSAS CITY, Kan., June 25, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and [...]
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
25/06/2024
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will [...]
TeamHealth Named Among Newsweek’s America’s Greatest Workplaces 2024
25/06/2024
KNOXVILLE, Tenn., June 25, 2024 (GLOBE NEWSWIRE) -- TeamHealth, the leading physician practice in the United States, today announced that it is recognized as one of America’s Greatest Workplaces for 2024 by Newsweek and [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
25/06/2024
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders [...]
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
25/06/2024
ASHBURN, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
25/06/2024
– AK006 achieved serum concentrations consistent with levels demonstrating inhibitory activity in preclinical experiments – – Skin biopsies from subjects treated with AK006 show high receptor occupancy – – AK006 was [...]
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
25/06/2024
First-ever clinical data demonstrating redosing with an investigational in vivo CRISPR-based therapy Follow-on dosing with a 55 mg dose of NTLA-2001 led to a 90% median reduction in serum TTR at day 28 in the three [...]
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
25/06/2024
Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion NOT FOR RELEASE, [...]
SAFE - Finalisation des plans de redressement - Reports de l’Assemblée Générale annuelle 2024 et de la publication du rapport financier annuel 2023
25/06/2024
Finalisation des plans de redressement Reports de l’Assemblée Générale annuelle 2024 et de la publication du rapport financier annuel 2023 Fleurieux-sur-l’Arbresle - France - le 25 juin 2024 à 20h . Safe (FR001400F1V2 [...]
Press Release: Availability of the Q2 2024 Aide-mémoire
25/06/2024
Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024 . Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/ [...]
Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 »
25/06/2024
Mise en ligne du document « Aide-mémoire Q2 2024 » Paris, France, le 25 juin 2024 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Aide-mémoire Q2 [...]
HFMA Announces Marc Scher as National Chair
25/06/2024
LAS VEGAS, June 25, 2024 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today during its annual conference inducted former KPMG LLP Partner Marc B. Scher, FHFMA, CPA, into office as its [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024
25/06/2024
Aggregated presentation by day and by market Purchases of own shares from June 17th to 21th 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2024
25/06/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 17 au 21 juin 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Higher cantonal composition authority approved the amendments to the terms of the 2024 convertible bonds
25/06/2024
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2024 Idorsia Ltd (SIX: IDIA) today announced that the hearing by the higher cantonal composition authority ( obere kantonale Nachlassbehörde [...]
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
25/06/2024
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN [...]
CORRECTION: Capricor Therapeutics
25/06/2024
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, [...]
Ursula Burns, former Xerox CEO, and Jordan Wertlieb, EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board as inaugural members
25/06/2024
Renowned business leaders Burns and Wertlieb to serve as special advisors to PBTF Board of Directors NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- The Pediatric Brain Tumor Foundation (PBTF) today announced the [...]

Pages